Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate

British Journal of Clinical Pharmacology

Volumn 43, Issue 6, 1997, Pages 633-637

  Golding, J F ^a   Stott, J R R ^b  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Coriolis; Heart rate; Hyoscine; Motion sickness; Muscarinic receptors M3 m5; Skin conductance

Indexed keywords

MUSCARINIC M3 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; SCOPOLAMINE; UNCLASSIFIED DRUG; ZAMIFENACIN;

ADULT; ARTICLE; CLINICAL TRIAL; CORIOLIS PHENOMENON; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HEAD MOVEMENT; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MOTION SICKNESS; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULSE RATE; SACCADIC EYE MOVEMENT; SKIN CONDUCTANCE; SWEATING; VESTIBULOOCULAR REFLEX; XEROSTOMIA;

EID: 0030744346     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00606.x     Document Type: Article

References (14)

1. Wood CD. Antimotion sickness and antiemetic drugs. Drugs 1979; 17: 471-479.
2. Hulme EC, Birdsall NJM, Buckley NJ. Muscarinic receptor subtypes Ann Rev Pharmacol Toxicol 1990; 30: 633-73.
3. Reason, J, Brand, J. Motion sickness. 1975. London: Academic Press.
4. 3-receptor antagonist with anti-emetic properties Br J Clin Pharmacol 1989; 27: 147-157.
5. Golding JF, Kerguelen M. A comparison of the nauseogenic potential of low-frequency vertical versus horizontal linear oscillation. Aviat Space Environ Med 1992; 63: 491-497.
6. Golding JF. Phasic skin conductance activity and motion sickness. Aviat Space Environ Med 1992; 63: 165-171.
7. Nordin, M. Sympathetic discharges in the human supra-orbital nerve and their relationship to sudo- and vasomotor responses. J Physiol 1990; 423: 241-255.
8. Venables, PH, Christie, MJ. Electrodermal activity. Chapter 1. Techniques in Psychophysiology. eds Martin, I, Venables, PH. 1980. Chichester, UK: J. Wiley & Sons, pp 3-67.
9. Barnes GR. A procedure for the analysis of nystagmus and other eye movements Aviat Space Environ Med 1982; 53: 676-682.
10. Barnes GR, Donnelly SF, Eason RD. Predictive velocity estimation in the pursuit reflex response to pseudo-random and step displacement stimuli in man. J Physiol 1987; 389: 111-136.
11. Hodgson M, Golding JF. Psychometric evaluation of divers performing a series of Heliox non-saturation dives. Aviat Space Environ Med 1991; 62: 407-413.
12. Lucot JB, Charldorp KJ van, Tulp M TH M. Idaverine, an M2- vs. M3-selective muscarinic antagonist, does not prevent motion sicknes in cats. Pharmacol Biochem Behav 1991; 40: 345-349.
13. Brown JH. Atropine, scopolamine, and related antimuscarinic drugs. In The pharmacological basis of therapeutics 8th edition. eds., A Goodman Gilman, TW Rall, AS Nies, P Taylor, pp 150-165. Pergamon Press, New York. 1990.
14. Schiavone A, Brambilla A. Muscarinic M3 receptors mediate secretion from sweat glands in the rat. Pharmacological Research 1991; 23: 233-239.